We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LION
826
DELISTED
Fidelity Southern Corporation
LION
-72,824
Closed -$2.27M
WBK
827
DELISTED
Westpac Banking Corporation
WBK
-56
Closed -$1.12M
CELG
828
DELISTED
Celgene Corp
CELG
-762,400
Closed -$70.2M
AUO
829
DELISTED
AU Optronics Corp
AUO
-96,327
Closed -$284K
TRCO
830
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
-332,834
Closed -$15.3M
TSS
831
DELISTED
Total System Services, Inc.
TSS
-112,342
Closed -$14.3M
VG
832
CALL
DELISTED
Vonage Holdings Corporation
VG
-151,850
Closed -$2.15M
RHT
833
DELISTED
Red Hat Inc
RHT
-51,487
Closed -$9.63M
FNSR
834
DELISTED
Finisar Corp
FNSR
-120,045
Closed -$2.73M
FDC
835
DELISTED
First Data Corporation
FDC
-478,773
Closed -$12.9M
TCF
836
DELISTED
TCF Financial Corporation
TCF
-771,203
Closed -$16M

Similar funds

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.